Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-O!B activators for the treatment of ALS
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action
Thrombospondin-1 regulation of latent TGF-[beta] activation: A therapeutic target for fibrotic disease
SRI36160 is a specific inhibitor of Wnt/[beta]-catenin signaling in human pancreatic and colorectal cancer cells
GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer.
Effects of PD 128763, a New Potent Inhibitor of Poly(ADP-Ribose) Polymerase, on X-Ray-Induced Cellular Recovery Processes in Chinese Hamster V79 Cells
AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for alzheimer disease
Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides.
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.
Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.
Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma
Role of Adiponectin in the Metabolic Syndrome: Current Perspectives on its Modulation as a Treatment Strategy
The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer.
Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer".
Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Use of pentafluorophenyl esters for one-pot protection/activation of amino and thiol carboxylic acids
ChemInform Abstract: Novel Inhibitors of AP-1 and NF-ϰB Mediated Gene Expression: Structure-Activity Relationship Studies of Ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino] -2-(trifluoromethyl)pyrimidine-5-carboxylate.
Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.
Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS.
The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies
Triamterene normalizes glycosaminoglycan accumulation in an IDUA-W402X mouse model of MPS I (Hurler syndrome) via nonsense suppression.
Retraction notice to "SRI36160 is a specific inhibitor of Wnt/
-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
- 1-49 of 49 results for ""Suto, Mark""